Combined analysis of miRNA‐181a with phase angle derived from bioelectrical impedance predicts radiotherapy‐induced changes in body composition and survival of male patients with head and neck cancer

Head & Neck ◽  
2019 ◽  
Vol 41 (9) ◽  
pp. 3247-3257
Author(s):  
Tomasz Powrózek ◽  
Anna Brzozowska ◽  
Marcin Mazurek ◽  
Radosław Mlak ◽  
Grzegorz Sobieszek ◽  
...  

In Vivo ◽  
2019 ◽  
Vol 33 (5) ◽  
pp. 1645-1651 ◽  
Author(s):  
TERESA MAŁECKA-MASSALSKA ◽  
TOMASZ POWRÓZEK ◽  
MONIKA PRENDECKA ◽  
RADOSŁAW MLAK ◽  
GRZEGORZ SOBIESZEK ◽  
...  


2016 ◽  
Vol 23 (5) ◽  
pp. 481 ◽  
Author(s):  
M.S. Wladysiuk ◽  
R. Mlak ◽  
K. Morshed ◽  
W. Surtel ◽  
A. Brzozowska ◽  
...  

Background Phase angle could be an alternative to subjective global assessment for the assessment of nutrition status in patients with head-and-neck cancer.Methods We prospectively evaluated a cohort of 75 stage iiib and iv head-and-neck patients treated at the Otolaryngology Department, Head and Neck Surgery, Medical University of Lublin, Poland. Bioelectrical impedance analysis was performed in all patients using an analyzer that operated at 50 kHz. The phase angle was calculated as reactance divided by resistance (Xc/R) and expressed in degrees. The Kaplan–Meier method was used to calculate survival.Results Median overall survival in the cohort was 32.0 months. At the time of analysis, 47 deaths had been recorded in the cohort (62.7%). The risk of shortened overall survival was significantly higher in patients whose phase angle was less than 4.733 degrees than in the remaining patients (19.6 months vs. 45 months, p = 0.0489; chi-square: 3.88; hazard ratio: 1.8856; 95% confidence interval: 1.0031 to 3.5446).Conclusions Phase angle might be prognostic of survival in patients with advanced head-and-neck cancer. Further investigation in a larger population is required to confirm our results.



2019 ◽  
Author(s):  
Aaron J. Grossberg ◽  
Crosby D. Rock ◽  
Jared Edwards ◽  
Abdallah S.R. Mohamed ◽  
Debra Ruzensky ◽  
...  

AbstractImportanceDepleted skeletal muscle mass (sarcopenia) is associated with decreased survival and cancer control in head and neck cancer patients treated with radiotherapy. There is a need for validated measures of body composition that can be implemented in routine clinical workflow.ObjectiveTo validate the use of bioelectrical impedance analysis (BIA) for body composition analysis and diagnosis of sarcopenia in head and neck cancer patients.DesignIn this prospective observational cohort study, baseline 50 patients with head and neck cancer undergoing radiation therapy (RT) were enrolled between February 2016 and March 2017. Baseline BIA measures of skeletal muscle (SM) mass, fat-free mass (FMM), and fat mass (FM) were compared to CT-based estimates of body composition using linear regression. Sex-specific BIA-derived thresholds for sarcopenia were defined by the maximum Youden Index on receiver operator characteristic (ROC) curves of BIA against CT-defined sarcopenia. Changes in body composition across treatment were compared against changes in body weight using linear regression.ParticipantsIn total, 50 patients with pathologically confirmed stage I to IVB non-metastatic head and neck cancer treated with definitive radiation therapy were enrolled.SettingSingle academic referral center.Main Outcome and MeasureThe primary outcome was relative agreement between baseline lean body mass and fat body mass predicted from BIA measurement and CT imaging.ResultsOf the 48 evaluable patients 16 (33.3%) were sarcopenic at baseline based on CT analysis. BIA measures of body composition were strongly correlated with CT measures: SM mass (r = 0.97; R2 = 0.94; p < 0.0001), FFM (r = 0.97; R2 = 0.94; p < 0.0001) and FM (r = 0.95; R2 = 0.90; p < 0.0001). Relationship with normalized indices of SM mass, FFM, and FM was similar between BIA and CT, but not BIA and body mass index (BMI). Patients lost a mean of 5.7 ± 5.8 kg during treatment, of which 1.5 ± 1.9 kg was SM, 2.6 ± 3.3 kg was FFM, and 2.2 ± 2.6 kg was FM. Eight additional patients developed sarcopenia by the end of RT.ConclusionsBIA provides accurate estimates of body composition in head and neck cancer patients. Implementation of BIA in clinical practice may identify patients with sarcopenia.Trial RegistrationClinicalTrials.gov identifier: NCT02615275



2019 ◽  
Vol 139 (4) ◽  
pp. 383-387 ◽  
Author(s):  
Marie Lundberg ◽  
Amy Dickinson ◽  
Pia Nikander ◽  
Helena Orell ◽  
Antti Mäkitie


Head & Neck ◽  
2013 ◽  
pp. n/a-n/a ◽  
Author(s):  
William Jackson ◽  
Neil Alexander ◽  
Matthew Schipper ◽  
Lorraine Fig ◽  
Felix Feng ◽  
...  


2014 ◽  
Vol 90 (1) ◽  
pp. S781-S782
Author(s):  
P. Widlak ◽  
K. Jelonek ◽  
M. Ros ◽  
M. Pietrowska ◽  
T. Rutkowski ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document